Report Detail

Request for Sample of this report

Chemical & Material Global Gandotinib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4512637
    • |
  • 16 February, 2023
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

Gandotinib is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
According to our (Global Info Research) latest study, the global Gandotinib market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Gandotinib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Gandotinib market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Gandotinib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Gandotinib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Gandotinib market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gandotinib
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gandotinib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioVision, Selleck Chemicals, BOC Sciences, TargetMol and MyBiosource, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Gandotinib market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Market segment by Application
Research
Medical
Major players covered
BioVision
Selleck Chemicals
BOC Sciences
TargetMol
MyBiosource
Adooq Bioscience
Toronto Research Chemicals
AbMole
Taiclone
Axon Medchem
CSNpharm
AA BLOCKS
MedKoo
Wuhan Sun-Shine Bio-Technology
Biosynth Carbosynth
Biorbyt
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gandotinib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gandotinib, with price, sales, revenue and global market share of Gandotinib from 2018 to 2023.
Chapter 3, the Gandotinib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gandotinib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Gandotinib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gandotinib.
Chapter 14 and 15, to describe Gandotinib sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Gandotinib
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Gandotinib Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Min Purity Less Than 98%
    • 1.3.3 Min Purity 98%-99%
    • 1.3.4 Min Purity More Than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Gandotinib Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medical
  • 1.5 Global Gandotinib Market Size & Forecast
    • 1.5.1 Global Gandotinib Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Gandotinib Sales Quantity (2018-2029)
    • 1.5.3 Global Gandotinib Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 BioVision
    • 2.1.1 BioVision Details
    • 2.1.2 BioVision Major Business
    • 2.1.3 BioVision Gandotinib Product and Services
    • 2.1.4 BioVision Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 BioVision Recent Developments/Updates
  • 2.2 Selleck Chemicals
    • 2.2.1 Selleck Chemicals Details
    • 2.2.2 Selleck Chemicals Major Business
    • 2.2.3 Selleck Chemicals Gandotinib Product and Services
    • 2.2.4 Selleck Chemicals Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Selleck Chemicals Recent Developments/Updates
  • 2.3 BOC Sciences
    • 2.3.1 BOC Sciences Details
    • 2.3.2 BOC Sciences Major Business
    • 2.3.3 BOC Sciences Gandotinib Product and Services
    • 2.3.4 BOC Sciences Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 BOC Sciences Recent Developments/Updates
  • 2.4 TargetMol
    • 2.4.1 TargetMol Details
    • 2.4.2 TargetMol Major Business
    • 2.4.3 TargetMol Gandotinib Product and Services
    • 2.4.4 TargetMol Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 TargetMol Recent Developments/Updates
  • 2.5 MyBiosource
    • 2.5.1 MyBiosource Details
    • 2.5.2 MyBiosource Major Business
    • 2.5.3 MyBiosource Gandotinib Product and Services
    • 2.5.4 MyBiosource Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 MyBiosource Recent Developments/Updates
  • 2.6 Adooq Bioscience
    • 2.6.1 Adooq Bioscience Details
    • 2.6.2 Adooq Bioscience Major Business
    • 2.6.3 Adooq Bioscience Gandotinib Product and Services
    • 2.6.4 Adooq Bioscience Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Adooq Bioscience Recent Developments/Updates
  • 2.7 Toronto Research Chemicals
    • 2.7.1 Toronto Research Chemicals Details
    • 2.7.2 Toronto Research Chemicals Major Business
    • 2.7.3 Toronto Research Chemicals Gandotinib Product and Services
    • 2.7.4 Toronto Research Chemicals Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Toronto Research Chemicals Recent Developments/Updates
  • 2.8 AbMole
    • 2.8.1 AbMole Details
    • 2.8.2 AbMole Major Business
    • 2.8.3 AbMole Gandotinib Product and Services
    • 2.8.4 AbMole Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 AbMole Recent Developments/Updates
  • 2.9 Taiclone
    • 2.9.1 Taiclone Details
    • 2.9.2 Taiclone Major Business
    • 2.9.3 Taiclone Gandotinib Product and Services
    • 2.9.4 Taiclone Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Taiclone Recent Developments/Updates
  • 2.10 Axon Medchem
    • 2.10.1 Axon Medchem Details
    • 2.10.2 Axon Medchem Major Business
    • 2.10.3 Axon Medchem Gandotinib Product and Services
    • 2.10.4 Axon Medchem Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Axon Medchem Recent Developments/Updates
  • 2.11 CSNpharm
    • 2.11.1 CSNpharm Details
    • 2.11.2 CSNpharm Major Business
    • 2.11.3 CSNpharm Gandotinib Product and Services
    • 2.11.4 CSNpharm Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 CSNpharm Recent Developments/Updates
  • 2.12 AA BLOCKS
    • 2.12.1 AA BLOCKS Details
    • 2.12.2 AA BLOCKS Major Business
    • 2.12.3 AA BLOCKS Gandotinib Product and Services
    • 2.12.4 AA BLOCKS Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 AA BLOCKS Recent Developments/Updates
  • 2.13 MedKoo
    • 2.13.1 MedKoo Details
    • 2.13.2 MedKoo Major Business
    • 2.13.3 MedKoo Gandotinib Product and Services
    • 2.13.4 MedKoo Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 MedKoo Recent Developments/Updates
  • 2.14 Wuhan Sun-Shine Bio-Technology
    • 2.14.1 Wuhan Sun-Shine Bio-Technology Details
    • 2.14.2 Wuhan Sun-Shine Bio-Technology Major Business
    • 2.14.3 Wuhan Sun-Shine Bio-Technology Gandotinib Product and Services
    • 2.14.4 Wuhan Sun-Shine Bio-Technology Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Wuhan Sun-Shine Bio-Technology Recent Developments/Updates
  • 2.15 Biosynth Carbosynth
    • 2.15.1 Biosynth Carbosynth Details
    • 2.15.2 Biosynth Carbosynth Major Business
    • 2.15.3 Biosynth Carbosynth Gandotinib Product and Services
    • 2.15.4 Biosynth Carbosynth Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Biosynth Carbosynth Recent Developments/Updates
  • 2.16 Biorbyt
    • 2.16.1 Biorbyt Details
    • 2.16.2 Biorbyt Major Business
    • 2.16.3 Biorbyt Gandotinib Product and Services
    • 2.16.4 Biorbyt Gandotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Biorbyt Recent Developments/Updates

3 Competitive Environment: Gandotinib by Manufacturer

  • 3.1 Global Gandotinib Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Gandotinib Revenue by Manufacturer (2018-2023)
  • 3.3 Global Gandotinib Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Gandotinib by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Gandotinib Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Gandotinib Manufacturer Market Share in 2022
  • 3.5 Gandotinib Market: Overall Company Footprint Analysis
    • 3.5.1 Gandotinib Market: Region Footprint
    • 3.5.2 Gandotinib Market: Company Product Type Footprint
    • 3.5.3 Gandotinib Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Gandotinib Market Size by Region
    • 4.1.1 Global Gandotinib Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Gandotinib Consumption Value by Region (2018-2029)
    • 4.1.3 Global Gandotinib Average Price by Region (2018-2029)
  • 4.2 North America Gandotinib Consumption Value (2018-2029)
  • 4.3 Europe Gandotinib Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Gandotinib Consumption Value (2018-2029)
  • 4.5 South America Gandotinib Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Gandotinib Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Gandotinib Sales Quantity by Type (2018-2029)
  • 5.2 Global Gandotinib Consumption Value by Type (2018-2029)
  • 5.3 Global Gandotinib Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Gandotinib Sales Quantity by Application (2018-2029)
  • 6.2 Global Gandotinib Consumption Value by Application (2018-2029)
  • 6.3 Global Gandotinib Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Gandotinib Sales Quantity by Type (2018-2029)
  • 7.2 North America Gandotinib Sales Quantity by Application (2018-2029)
  • 7.3 North America Gandotinib Market Size by Country
    • 7.3.1 North America Gandotinib Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Gandotinib Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Gandotinib Sales Quantity by Type (2018-2029)
  • 8.2 Europe Gandotinib Sales Quantity by Application (2018-2029)
  • 8.3 Europe Gandotinib Market Size by Country
    • 8.3.1 Europe Gandotinib Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Gandotinib Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Gandotinib Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Gandotinib Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Gandotinib Market Size by Region
    • 9.3.1 Asia-Pacific Gandotinib Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Gandotinib Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Gandotinib Sales Quantity by Type (2018-2029)
  • 10.2 South America Gandotinib Sales Quantity by Application (2018-2029)
  • 10.3 South America Gandotinib Market Size by Country
    • 10.3.1 South America Gandotinib Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Gandotinib Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Gandotinib Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Gandotinib Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Gandotinib Market Size by Country
    • 11.3.1 Middle East & Africa Gandotinib Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Gandotinib Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Gandotinib Market Drivers
  • 12.2 Gandotinib Market Restraints
  • 12.3 Gandotinib Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Gandotinib and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Gandotinib
  • 13.3 Gandotinib Production Process
  • 13.4 Gandotinib Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Gandotinib Typical Distributors
  • 14.3 Gandotinib Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Gandotinib. Industry analysis & Market Report on Gandotinib is a syndicated market report, published as Global Gandotinib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Gandotinib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,225.96
    		4,838.94
    		6,451.92
    		542,984.40
    		814,476.60
    		1,085,968.80
    		290,649.60
    		435,974.40
    		581,299.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo